Influenza vaccine, surface antigen, inactivated (Ph.Eur. 2009-2010 formulation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Influenza vaccine, surface antigen, inactivated (Ph.Eur. 2009-2010 formulation), covering 2017-03-28 to 2017-03-28. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects [Phase 2]